David P. Macfarlane
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Hormonal Regulation and Hypertension
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Nephrology top 5%
Papers in
-
- Diabetes Treatment and Management 5
- Diabetes, Cardiovascular Risks, and Lipoproteins 3
- Hormonal Regulation and Hypertension 3
- Diet, Metabolism, and Disease 3
- Diabetic Foot Ulcer Assessment and Management 2
-
- Parathyroid Disorders and Treatments 3
- Co-authors
- Brian Robert Walker (6 shared papers)Shareen Forbes (1 shared paper)Ruth Andrew (6 shared papers)Dawn E. W. Livingstone (4 shared papers)Graham Leese (4 shared papers)Miles Fisher (3 shared papers)Ning Yu (3 shared papers)Thomas R. Konrad (1 shared paper)
- Journals
- Diabetes Obesity and Metabolism (3 papers)Diabetic Medicine (2 papers)The Lancet (2 papers)QJM (1 paper)American Journal of Cardiovascular Drugs (1 paper)
- Partner nations
- United KingdomAustraliaItaly
In The Last Decade
David P. Macfarlane
25 papers receiving 3.6k citations
David P. Macfarlane's Hit Papers
Peers
Comparison fields: 5 of 101
- Endocrinology, Diabetes and Metabolism 2.6k
- Nephrology 170
- Pharmacology 344
- Cardiology and Cardiovascular Medicine 348
- Behavioral Neuroscience 54
Countries citing papers authored by David P. Macfarlane
This map shows the geographic impact of David P. Macfarlane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David P. Macfarlane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David P. Macfarlane more than expected).
Fields of papers citing papers by David P. Macfarlane
This network shows the impact of papers produced by David P. Macfarlane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David P. Macfarlane. The network helps show where David P. Macfarlane may publish in the future.
Co-authors
The 25 scholars most cited alongside David P. Macfarlane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hit paper breakdown → | 2019 | 2307 |
| 2 | Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hit paper breakdown → | 2019 | 492 |
| 3 | 2008 | 308 | |
| 4 | 2010 | 92 | |
| 5 | 2014 | 78 | |
| 6 | 2010 | 77 | |
| 7 | 2014 | 72 | |
| 8 | 2017 | 52 | |
| 9 | 2013 | 27 | |
| 10 | 2006 | 26 | |
| 11 | 2010 | 25 | |
| 12 | 2014 | 24 | |
| 13 | 2020 | 22 | |
| 14 | 2011 | 16 | |
| 15 | 1999 | 13 | |
| 16 | 2015 | 12 | |
| 17 | 2006 | 12 | |
| 18 | 2018 | 11 | |
| 19 | 2010 | 8 | |
| 20 | 2013 | 7 |
About David P. Macfarlane
David P. Macfarlane is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Occupational Therapy, Cardiology and Cardiovascular Medicine and Rehabilitation, having authored 26 papers that have together received 3.7k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Parathyroid Disorders and Treatments (3 papers), Hormonal Regulation and Hypertension (3 papers), Diet, Metabolism, and Disease (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Cardiovascular Function and Risk Factors (2 papers) and Diabetic Foot Ulcer Assessment and Management (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.6k citations), Nephrology (170 citations), Pharmacology (344 citations), Cardiology and Cardiovascular Medicine (348 citations) and Behavioral Neuroscience (54 citations). David P. Macfarlane has collaborated with scholars based in United Kingdom, Australia and Italy. Frequent co-authors include Brian Robert Walker, Shareen Forbes, Ruth Andrew, Dawn E. W. Livingstone, Graham Leese, Miles Fisher, Ning Yu, Thomas R. Konrad, Simona Panunzi and Olle Melander. Their work appears in journals such as Diabetes Obesity and Metabolism, Diabetic Medicine, The Lancet, QJM and American Journal of Cardiovascular Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.